問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

陳滄山
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2021-05-20 - 2026-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting2Sites

Terminated3Sites

2016-02-01 - 2020-04-02

Phase III

A Phase 3, randomized, double-blind, placebo-controlled study to evaluate LY2951742 in patients with chronic migraine — the REGAIN trial.
  • Condition/Disease

    Chronic migraine

  • Test Drug

    LY2951742

Participate Sites
5Sites

Terminated5Sites